TLDR
- Memory stocks like Sandisk, Western Digital, and Micron fell over 3% in premarket Thursday after sharp drops Wednesday
- Software stocks ServiceNow, Oracle, and Adobe continued to rise, signaling a market rotation
- Palantir rose over 3% after its Nvidia AI partnership announcement for the U.S. government
- Crypto gains pushed Strategy up more than 5%, with Coinbase and Robinhood also rising
- National Beverage surged 6% after declaring a special dividend; Embraer fell 5% after an acquisition
Memory chip and storage stocks continued to slide Thursday, a day after some of the biggest single-session drops of the year.
Sandisk fell more than 10% Wednesday and was down again in premarket. Western Digital dropped over 6%, and Seagate Technology also declined. Micron Technology slid 2.7% Thursday after a 10.6% drop the session before.
Sandisk Corporation, SNDK
The selloff spread to related hardware names. Corning fell 2.6% and Dell Technologies dropped 2.7% in premarket trading.
Software Stocks Keep Rising
While hardware names struggled, software stocks moved higher. ServiceNow, Oracle, and Adobe each traded up, continuing a rotation that has been building over recent sessions.
New listing Bending Spoons, the AOL parent that surged 40% on its debut Wednesday, pulled back around 3% ahead of Thursday’s open.
Palantir Climbs on Nvidia AI Deal
Palantir was up more than 3% Thursday, extending a 7.8% gain from Wednesday. The company announced a strategic initiative with Nvidia on Monday to build custom AI models for the U.S. government.
Advanced Micro Devices slipped 2%, moving further from the trillion-dollar market cap threshold. The company’s valuation dropped from $947 billion Tuesday to $881 billion Wednesday. Intel and Marvell Technology also fell more than 2%.
Higher crypto prices lifted Strategy, the largest corporate Bitcoin holder, by more than 5%. Robinhood Markets gained 2.6% and Coinbase Global rose 3%.
National Beverage, maker of LaCroix sparkling water, jumped 6% after declaring a special cash dividend of $3.25 per share. The company reported full-year net sales of $1.2 billion and earnings per share of $1.96.
Can-Fite BioPharma dropped 12% despite reporting positive Phase 2a trial data for its pancreatic cancer drug Namodenoson. The trial met its primary safety endpoint, and the company plans to move into a Phase 2b study.
Embraer fell 5% after completing its buyout of Safran Cabin’s 50% stake in an aircraft interior joint venture. The Mexico-based facility makes components for Embraer’s E-Jet family. Financial terms were not disclosed.
Stock futures pointed lower broadly on Thursday, with markets winding down a holiday-shortened week ahead of America’s 250th Independence Day.
Investors are watching Friday’s June jobs report closely. U.S.-Iran diplomatic talks in Doha are also keeping sentiment cautious heading into the long weekend.
🚨 Our July Stock Picks Are Live!
A new month means new opportunities. Our analysts have just released their top stock picks for July, highlighting companies with strong momentum that rank highly on our KO Score algorithm. We’re also now sharing trade ideas for both long-term and short-term investors, giving you more ways to spot potential opportunities in the market.
Sign up to Knockout Stocks today and get 50% off to unlock the full list and see which stocks made the cut.
Use coupon code Special50 for your exclusive discount!
Be the first to comment